NCT03212248 (TUS-STRAT) is a clinical trial of Thoracic Ultrasound (TUS) in Difference, Individual, sponsored by Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele.

Who is sponsoring NCT03212248?

NCT03212248 is sponsored by Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele.

What drugs are being tested in NCT03212248?

Interventions in NCT03212248: Thoracic Ultrasound (TUS).

What condition does NCT03212248 study?

NCT03212248 studies Difference, Individual, Community-acquired Pneumonia, Ultrasound.

Is NCT03212248 still recruiting?

NCT03212248 is currently completed. Last updated 11 July 2017.

Last reviewed 2017-07-11 · How we verify

NCT03212248: TUS-STRAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CRP and Thoracic Emergency Ultrasound in Pneumonia

Completed Last updated 11 July 2017

What this trial tests

trial testing Thoracic Ultrasound (TUS) in Difference, Individual in 70 participants. Completed in 30 June 2017.

Timeline

2 January 2016

Primary endpoint
30 April 2016

30 June 2017

Quick facts

Lead sponsor	Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele
Status	Completed
Study type	OBSERVATIONAL
Enrollment	70
Start date	2 January 2016
Primary completion	30 April 2016
Estimated completion	30 June 2017
Sites	1 location across Italy

Drugs / interventions tested

Thoracic Ultrasound (TUS)

Conditions studied

Difference, Individual — all drugs for Difference, Individual →
Community-acquired Pneumonia — all drugs for Community-acquired Pneumonia →
Ultrasound — all drugs for Ultrasound →

Sponsor

Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele

Who can join

Adults 19 to 75, any sex, with Difference, Individual or Community-acquired Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This preliminary study investigates in patients with possible clinical diagnosis of pneumonia, clues and biomarker assessed at Emergency Department (ED) triage, potentially predicting detection of lung consolidation by Thoracic-ultrasound (TUS) and/or by Chest-X-Rays. Cough and high admission CRP levels will be defined according to the cutoff defined by ROC analysis, will be challenged if independently associated with TUS lung consolidation detection High level of the chosen biomarker, and any of the considered symptoms, in otherwise not extremely critical patients (CURB65≤3), should prompt to immediate confirm by TUS, during the physical examination. This may limit the need of further radiological investigations allowing targeted workup.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele trials

Trials by the same sponsor.

NCT05721313 — Vital Root Amputation in Molars With Advanced Periodontal Furcation Involvement: a Preliminary Study · NA · unknown
NCT03226665 — Ultrasound Emergency Diagnosis of Small Bowel Obstruction · unknown
NCT03743870 — Spinal Anesthesia in Caesarean Section · unknown
NCT03407911 — Microbiota Around Periodontal Teeth and Implants Affected by Peri-implant Disease. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03212248 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele
Last refreshed: 11 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03212248.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing